Gildea Edward J 4

What Happened

• Edward J. Gildea, a director of Marimed Inc. (MRMD), converted/exercised 75,000 restricted stock units (RSUs) into 75,000 shares of common stock on June 12, 2026. The conversion shows an acquisition of 75,000 shares at $0.00 and a corresponding disposition entry for 75,000 RSU derivatives at $0.00.

Key Details

• Transaction date: 2026-06-12; Transaction code: M (exercise/conversion of derivative)
• Price: $0.00 per share; Shares acquired: 75,000 common shares
• Disposition: 75,000 RSU derivatives terminated/converted (reported as $0)
• Shares owned after transaction: Not specified in the filing
• Footnotes: (F1) RSUs convert to common stock on a one-for-one basis. (F2) These RSUs were granted on June 12, 2025 and there are no RSUs remaining under that grant per the award terms.
• Filing timeliness: Reporting period and filing date are the same (no late filing indicated)

Context

• This was a conversion of previously granted RSUs into common stock (an award vesting/settlement), not an open-market purchase or sale of existing shares. Such conversions often reflect vesting or settlement of compensation awards rather than a deliberate buy/sell decision by the insider.